Federal Register: FDA Issues Notice on Determination That Prednisolone Tablet, 5 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
June 26, 2026
June 26, 2026
WASHINGTON, June 26 (TNSFR) -- The Food and Drug Administration (FDA) has determined that prednisolone tablet, 5 milligrams, was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.
. . .
. . .